D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.68B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$875M |
| 4 |
Tesla
TSLA
|
+$835M |
| 5 |
Eli Lilly
LLY
|
+$643M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$939M |
| 2 |
Palantir
PLTR
|
+$668M |
| 3 |
Apple
AAPL
|
+$644M |
| 4 |
Workday
WDAY
|
+$525M |
| 5 |
Spotify
SPOT
|
+$451M |
Sector Composition
| 1 | Technology | 20.55% |
| 2 | Consumer Discretionary | 13.27% |
| 3 | Healthcare | 12.29% |
| 4 | Financials | 8.39% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPI
1301
Office Properties Income Trust
OPI
$40.8M
| $3.96M | ﹤0.01% |
3,965,620
+2,636,589
| +198% | +$2.64M |
|
1302
Driven Brands
DRVN
$3B
| $3.96M | ﹤0.01% |
245,271
-258,068
| -51% | -$4.17M |
|
1303
Caleres
CAL
$503M
| $3.95M | ﹤0.01% |
170,735
+29,880
| +21% | +$692K |
|
1304
Imperial Oil
IMO
$46.3B
| $3.93M | ﹤0.01% |
63,878
+8,588
| +16% | +$529K |
|
1305
Digimarc
DMRC
$204M
| $3.93M | ﹤0.01% |
105,028
+50,690
| +93% | +$1.9M |
|
1306
Stifel
SF
$11.8B
| $3.93M | ﹤0.01% |
37,068
-35,955
| -49% | -$3.81M |
|
1307
First Internet Bancorp
INBK
$212M
| $3.93M | ﹤0.01% |
109,121
-8,011
| -7% | -$288K |
|
1308
Neurocrine Biosciences
NBIX
$14.1B
| $3.92M | ﹤0.01% |
28,710
-140,744
| -83% | -$19.2M |
|
|
SAGE
1309
DELISTED
Sage Therapeutics
SAGE
| $3.91M | ﹤0.01% |
720,105
+73,073
| +11% | +$397K |
|
1310
Strategy Inc Common Stock Class A
MSTR
$94B
| $3.91M | ﹤0.01% |
+13,500
| New | +$3.91M |
|
1311
BrightView Holdings
BV
$1.32B
| $3.91M | ﹤0.01% |
244,337
-43,303
| -15% | -$692K |
|
1312
Itron
ITRI
$5.47B
| $3.87M | ﹤0.01% |
35,662
-33,062
| -48% | -$3.59M |
|
1313
H.B. Fuller
FUL
$3.33B
| $3.87M | ﹤0.01% |
+57,300
| New | +$3.87M |
|
1314
Olympic Steel
ZEUS
$368M
| $3.87M | ﹤0.01% |
117,842
+37,834
| +47% | +$1.24M |
|
1315
GSK
GSK
$82.2B
| $3.86M | ﹤0.01% |
114,110
-8,746
| -7% | -$296K |
|
|
BWIN
1316
Baldwin Insurance Group
BWIN
$2.22B
| $3.86M | ﹤0.01% |
+99,562
| New | +$3.86M |
|
1317
Sabra Healthcare REIT
SBRA
$4.57B
| $3.84M | ﹤0.01% |
221,992
+195,854
| +749% | +$3.39M |
|
1318
Calix
CALX
$4.01B
| $3.84M | ﹤0.01% |
+110,231
| New | +$3.84M |
|
1319
Tapestry
TPR
$22.2B
| $3.84M | ﹤0.01% |
58,815
-934,512
| -94% | -$61.1M |
|
1320
Coinbase
COIN
$83B
| $3.82M | ﹤0.01% |
15,400
+2,400
| +18% | +$596K |
|
1321
Wynn Resorts
WYNN
$12.6B
| $3.82M | ﹤0.01% |
44,297
-211,121
| -83% | -$18.2M |
|
1322
Prudential Financial
PRU
$37.6B
| $3.8M | ﹤0.01% |
32,041
+20,121
| +169% | +$2.38M |
|
1323
Porch Group
PRCH
$1.82B
| $3.79M | ﹤0.01% |
771,233
+142,146
| +23% | +$699K |
|
1324
World Acceptance Corp
WRLD
$900M
| $3.78M | ﹤0.01% |
33,632
+4,329
| +15% | +$487K |
|
|
RANGU
1325
Range Capital Acquisition Corp. Units
RANGU
| $3.77M | ﹤0.01% |
+375,000
| New | +$3.77M |
|